The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Abstract
The present immunohistochemical study provides evidence that the kynurenine pathway is up‐regulated in Alzheimer's disease (AD) brain, leading to increases in the excitotoxin quinolinic acid (QUIN). We show that the regulatory enzyme of the pathway leading to QUIN synthesis, indoleamine 2,3 dioxygenase (IDO) is abundant in AD compared with controls. In AD hippocampus, both IDO‐ and QUIN‐immunoreactivity (‐IR) was detected in cortical microglia, astrocytes and neurones, with microglial and astrocytic expression of IDO and QUIN highest in the perimeter of senile plaques. QUIN‐IR was present in granular deposits within the neuronal soma of AD cortex and was also seen uniformly labelling neurofibrillary tangles. Our data imply that QUIN may be involved in the complex and multifactorial cascade leading to neuro‐degeneration in AD. These results may open a new therapeutic door for AD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948
HEYES, M. P., SAITO, K., CROWLEY, J. S., DAVIS, L. E., DEMITRACK, M. A., DER, M., DILLING, L. A., ELIA, J., KRUESI, M. J. P., LACKNER, A., et al. (1992) · Brain · doi:10.1093/brain/115.5.1249 · Cited by 680
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
Guillemin, G. J., Kerr, S. J., Smythe, G. A., Smith, D. G., Kapoor, V., Armati, P. J., Croitoru, J., & Brew, B. J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00498.x · Cited by 538
Self-citationGuillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497
Self-citationHuman macrophages convert l-tryptophan into the neurotoxin quinolinic acid
Heyes, M. P., Saito, K., & Markey, S. P. (1992) · Biochemical Journal · doi:10.1042/bj2830633 · Cited by 447
Tryptophan degradation and immune activation in Alzheimer's disease
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050029 · Cited by 286
Kynurenine metabolism in Alzheimer's disease
Baran, H., Jellinger, K., & Deecke, L. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050149 · Cited by 236
Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
HEYES, M. P., CHEN, C. Y., MAJOR, E. O., & SAITO, K. (1997) · Biochemical Journal · doi:10.1042/bj3260351 · Cited by 214
Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease
Guillemin, G. J., & Brew, B. J. (2002) · Redox Report · doi:10.1179/135100002125000550 · Cited by 212
Self-citationStone, T. W. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01451-6 · Cited by 211
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes
Guillemin, G. J., Croitoru‐Lamoury, J., Dormont, D., Armati, P. J., & Brew, B. J. (2003) · Glia · doi:10.1002/glia.10175 · Cited by 173
Self-citationEndogenous neurotoxins from tryptophan
Stone, T. W. (2001) · Toxicon · doi:10.1016/s0041-0101(00)00156-2 · Cited by 164
Quinolinic Acid Production by Macrophages Stimulated with IFN-γ, TNF-α, and IFN-α
PEMBERTON, L. A., KERR, S. J., SMYTHE, G., & BREW, B. J. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.589 · Cited by 149
Self-citationAβ1-42 induces production of quinolinic acid by human macrophages and microglia
Guillemin, G. J., Smythe, G. A., Veas, L. A., Takikawa, O., & Brew, B. J. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00005 · Cited by 141
Self-citationKerr, S. J., Armati, P. J., Guillemin, G. J., & Brew, B. J. (1998) · AIDS · doi:10.1097/00002030-199804000-00003 · Cited by 132
Self-citationDegradation of Tryptophan in Neurodegenerative Disorders
Widner, B., Leblhuber, F., Walli, J., Tilz, G. P., Demel, U., & Fuchs, D. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_19 · Cited by 74
Perivascular astrocytes within Alzheimerʼs disease plaques
Cullen, K. M. (1997) · Neuroreport · doi:10.1097/00001756-199705260-00033 · Cited by 57
Self-citationLehrmann, E., Molinari, A., Speciale, C., & Schwarcz, R. (2001) · Experimental Brain Research · doi:10.1007/s002210100887 · Cited by 38
Microglial in Neurodegenerative Disorders: Emphasis on Alzheimer’s Disease
McRae‐Degueurce, A., Dahlström, A. B., & Ling, E. A. (2009) · Gerontology · doi:10.1159/000213838 · Cited by 38
Stone, T. W., Behan, W. M. H., Jones, P. A., Darlington, L. G., & Smith, R. A. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3401 · Cited by 31
Alexander Disease: Alzheimer Disease of the Developing Brain?
Castellani, R. J., Perry, G. L., Brenner, D. S., et al. (1999) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199910000-00010 · Cited by 11
Cited by
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
“Indoleamine-2,3-dioxygenase (IDO) is an enzyme expressed in multiple cell types, including macrophages, dendritic cells, microglia, astrocytes, and neurons (Guillemin et al, 2005a, b, c; Huang et al, 2010).”
BackgroundTryptophan metabolism in health and disease
Xue, C., Li, G., Zheng, Q., Gu, X., Shi, Q., Su, Y., Chu, Q., Yuan, X., Bao, Z., Lu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.06.004 · Cited by 961
Metadata
- Authors
- Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2005-05-25
- Volume
- 31
- Issue
- 4
- Pages
- 395-404
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W1988691690
- Cited by
- 330
- References
- 24
- FWCI
- 4.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.